Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Skin Sciences Laboratory, Inc.
WARNING LETTER
•Skin Sciences Laboratory, Inc.•February 1, 2017

Skin Sciences Laboratory, Inc. – FDA Warning Letter, Feb 1, 2017

Record Details

The FDA issued a Warning Letter to Skin Sciences Laboratory, Inc. following a January 30 to February 1, 2017, inspection of their Pasig City, Philippines drug manufacturing facility. The inspection revealed significant violations of current good manufacturing practice (CGMP) regulations, rendering their drug products adulterated under 21 U.S.C. 351(a)(2)(B).

Key violations include: 1. **Lack of Finished Product Testing (21 CFR 211.165(a)):** The firm failed to test drug products for identity and strength of active ingredients prior to release. Their response to create an SOP was deemed inadequate as it did not address distributed lots. The FDA requires a detailed risk assessment for all in-expiry U.S. market products and testing of retain samples for identity and strength. 2. **Failure to Test Raw Materials (21 CFR 211.84(a)):** The firm failed to test glycerin raw material for diethylene glycol (DEG) contamination before use in drug manufacturing, including Essence Skin Saving Toothpaste. Their commitment to implement testing and test remaining stock was inadequate as it did not address distributed lots. The FDA requires a detailed risk assessment for all in-expiry U.S. market products containing glycerin and testing of retain samples for DEG.

Additionally, the firm manufactures and distributes unapproved new drugs and misbranded drugs: *

Company
Skin Sciences Laboratory, Inc.
Inspection date
February 1, 2017
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas J. Cosgrove
View Company Profile

ID · f72ece87-57fd-48fb-afff-aa7138da8152

Violation Codes10
21 CFR 21021 CFR 21121 CFR 211.165(a)21 CFR 211.84(a)21 CFR 350.50(d)FD&C Act 501(a)(2)(B)FD&C Act 505(a)21.U.S.C. 355(a)FD&C Act 502(f)(1)21 U.S.C. 352(f)(1)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Skin Sciences Laboratory, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.